Contact Supplier

Contact Supplier

To get in touch with PolyGene AG, simply fill out the form below.

Subscribe to Supplier

Subscribe to Supplier

PolyGene sharing latest transgenic and congenic animal insights at IMM Leiden

news-releasesPolyGene AG
June 2nd 2015

Rümlang, Switzerland: – Transgenic research specialists PolyGene AG will be sharing their insights on innovative genetic technologies and animal models at the upcoming 2015 IMM workshop at University of Leiden in the Netherlands.

PolyGene representatives will be there to provide insights based on the company’s latest innovations, such as sperm cryopreservation and strain recovery and GenoMouse™, its recently introduced speed congenics service that uses tetranucleotide microsatellite-based screening to establish mouse genetic background.

Innovative gene modification

Polygene’s scientists will also have valuable insights to contribute to discussion of the key topic at the workshop: CRISPR and Cas9-assisted gene modification.

The two-day workshop, opening June 11, is expected to attract some 150 participants from all over Europe, as well as Japan, Taiwan and USA. They will discuss a wide range of topics on the generation, management, preservation and distribution of mouse models for human disease and fundamental research by genetic modification.

Other key topics for this year’s IMM Workshop will include in recombineering, genome editing, iPS and ES cells, transposon screens, humanized mouse models, organoids, imaging, and cryopreservation.

Shortly after the IMM Workshop, the PolyGene team will also be attending the important TRIP meeting in Nantes, France.

About PolyGene

PolyGene is a privately owned research institute, located near Zurich, Switzerland, that develops state-of-the-art transgenic animal models of human disease for a worldwide research clientele.

Founded in 2002, PolyGene is run by an international team of scientists with academic and industrial backgrounds, having notable track records in mouse transgenesis as well as in business management.
The focus of the business is on finding and nurturing productive research collaborations that promote scientific advances.

PolyGene is a fully functional production site for the establishment and target validation of transgenic and knockout mouse lines, and also offers co-development opportunities in model building, including rat and rabbit models. PolyGene provides one of the in the world’s most highly regarded professional transgenic services, with some 500 completed customer projects and more than 750 individual mouse lines generated to date.

PolyGene’s strong IP portfolio includes patent rights on innovative antibiotic-inducible expression systems, used exclusively for transgenic service projects, such as the murine recombinant Leukemia Inhibitory Factor ESLIF that PolyGene has developed for the generation of highly chimeric mice.

PolyGene will also be talking about latest progress on EU initiatives in which it is a SME partner, such as Horizon 2020, Eurostars, IMI, etc.

About IMM 2015

The 8th International Workshop on Innovative Mouse Models (IMM) 2015 will be held 11-12 June at the Medical Centre of the University of Leiden in The Netherlands. IMM is a biannual event, last held in 2013.

The 2015 workshop agenda will focus on the use of CRISPR/Cas9-assisted gene modification as well as novel imaging-technologies. The event combines keynote lectures with presentations of selected abstracts in order to encourage in-depth academic discussions of novel technologies.

The IMM workshop also features a small exhibition in the poster area.

Keynote speakers for 2015 will represent universities and research institutes from the USA, Germany, The Netherlands, UK and Japan.

More information at:

Contact PolyGene AG

Simply fill out the form below to contact PolyGene AG now.

Send PolyGene AG a Message